These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 8340410)
1. Structure of the complex of proteinase K with a substrate analogue hexapeptide inhibitor at 2.2-A resolution. Betzel C; Singh TP; Visanji M; Peters K; Fittkau S; Saenger W; Wilson KS J Biol Chem; 1993 Jul; 268(21):15854-8. PubMed ID: 8340410 [TBL] [Abstract][Full Text] [Related]
2. Strategy to design peptide inhibitors: structure of a complex of proteinase K with a designed octapeptide inhibitor N-Ac-Pro-Ala-Pro-Phe-DAla-Ala-Ala-Ala-NH2 at 2.5 A resolution. Saxena AK; Singh TP; Peters K; Fittkau S; Betzel C Protein Sci; 1996 Dec; 5(12):2453-8. PubMed ID: 8976553 [TBL] [Abstract][Full Text] [Related]
3. Structure of a ternary complex of proteinase K, mercury, and a substrate-analogue hexa-peptide at 2.2 A resolution. Saxena AK; Singh TP; Peters K; Fittkau S; Visanji M; Wilson KS; Betzel C Proteins; 1996 Jun; 25(2):195-201. PubMed ID: 8811735 [TBL] [Abstract][Full Text] [Related]
4. The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity. Pereira PJ; Wang ZM; Rubin H; Huber R; Bode W; Schechter NM; Strobl S J Mol Biol; 1999 Feb; 286(1):163-73. PubMed ID: 9931257 [TBL] [Abstract][Full Text] [Related]
6. Three-dimensional structure of proteinase K at 0.15-nm resolution. Betzel C; Pal GP; Saenger W Eur J Biochem; 1988 Dec; 178(1):155-71. PubMed ID: 3203685 [TBL] [Abstract][Full Text] [Related]
7. Conserved mode of peptidomimetic inhibition and substrate recognition of human cytomegalovirus protease. Tong L; Qian C; Massariol MJ; Déziel R; Yoakim C; Lagacé L Nat Struct Biol; 1998 Sep; 5(9):819-26. PubMed ID: 9731777 [TBL] [Abstract][Full Text] [Related]
8. X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design. Grams F; Reinemer P; Powers JC; Kleine T; Pieper M; Tschesche H; Huber R; Bode W Eur J Biochem; 1995 Mar; 228(3):830-41. PubMed ID: 7737183 [TBL] [Abstract][Full Text] [Related]
9. Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures. Tong L; Pav S; Pargellis C; Dô F; Lamarre D; Anderson PC Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8387-91. PubMed ID: 8378311 [TBL] [Abstract][Full Text] [Related]
10. Crystal structures of alpha-lytic protease complexes with irreversibly bound phosphonate esters. Bone R; Sampson NS; Bartlett PA; Agard DA Biochemistry; 1991 Feb; 30(8):2263-72. PubMed ID: 1998685 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of proteinase K by methoxysuccinyl-Ala-Ala-Pro-Ala-chloromethyl ketone. An x-ray study at 2.2-A resolution. Wolf WM; Bajorath J; Müller A; Raghunathan S; Singh TP; Hinrichs W; Saenger W J Biol Chem; 1991 Sep; 266(26):17695-9. PubMed ID: 1894649 [TBL] [Abstract][Full Text] [Related]
12. High-resolution X-ray diffraction study of the complex between endothiapepsin and an oligopeptide inhibitor: the analysis of the inhibitor binding and description of the rigid body shift in the enzyme. Sali A; Veerapandian B; Cooper JB; Foundling SI; Hoover DJ; Blundell TL EMBO J; 1989 Aug; 8(8):2179-88. PubMed ID: 2676515 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and evaluation of matrix metalloprotease inhibitors bearing cyclopropane-derived peptidomimetics as P1' and P2' replacements. Reichelt A; Gaul C; Frey RR; Kennedy A; Martin SF J Org Chem; 2002 Jun; 67(12):4062-75. PubMed ID: 12054939 [TBL] [Abstract][Full Text] [Related]
14. X-ray and model-building studies on the specificity of the active site of proteinase K. Betzel C; Bellemann M; Pal GP; Bajorath J; Saenger W; Wilson KS Proteins; 1988; 4(3):157-64. PubMed ID: 3237715 [TBL] [Abstract][Full Text] [Related]
15. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution. Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y Biochemistry; 1996 Sep; 35(36):11570-6. PubMed ID: 8794736 [TBL] [Abstract][Full Text] [Related]
16. Crystal structure of papain-succinyl-Gln-Val-Val-Ala-Ala-p-nitroanilide complex at 1.7-A resolution: noncovalent binding mode of a common sequence of endogenous thiol protease inhibitors. Yamamoto A; Tomoo K; Doi M; Ohishi H; Inoue M; Ishida T; Yamamoto D; Tsuboi S; Okamoto H; Okada Y Biochemistry; 1992 Nov; 31(46):11305-9. PubMed ID: 1445868 [TBL] [Abstract][Full Text] [Related]
17. Crystal structure of calcium-free proteinase K at 1.5-A resolution. Müller A; Hinrichs W; Wolf WM; Saenger W J Biol Chem; 1994 Sep; 269(37):23108-11. PubMed ID: 8083213 [TBL] [Abstract][Full Text] [Related]
18. Crystal structure of a complex formed between proteolytically-generated lactoferrin fragment and proteinase K. Singh TP; Sharma S; Karthikeyan S; Betzel C; Bhatia KL Proteins; 1998 Oct; 33(1):30-8. PubMed ID: 9741842 [TBL] [Abstract][Full Text] [Related]
19. Structure of the Rhizomucor miehei aspartic proteinase complexed with the inhibitor pepstatin A at 2.7 A resolution. Yang J; Quail JW Acta Crystallogr D Biol Crystallogr; 1999 Mar; 55(Pt 3):625-30. PubMed ID: 10089458 [TBL] [Abstract][Full Text] [Related]
20. X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor. Swain AL; Miller MM; Green J; Rich DH; Schneider J; Kent SB; Wlodawer A Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8805-9. PubMed ID: 2247451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]